Skip to main content
. 2022 Jun 9;10:879612. doi: 10.3389/fcvm.2022.879612

TABLE 4.

Aortic valve surgery.

Pt Sex Age Euro
SCORE II
Creatinine Time to
CASH, y
Urgency Pathology Operation Concomitant
procedure
Complications Mortality Follow-up,
y
1 m 54.4 16.5 1.4 0.1 Urgent Regurgitation Mechanical valve CABG Bleeding, RRT, stroke, pneumonia MOF 0.1
2 m 52.9 6.7 1.2 2.0 Urgent Endocarditis Biological valve 7.7
3 m 59.3 2.7 n.a. 5.3 Elective Regurgitation Mechanical valve 0.5
4 m 62.3 15.8 4.4 7.1 Urgent Stenosis Mechanical valve Mitral + tricuspid RRT 0.9
5 m 61.3 2.8 1.7 9.7 Elective Stenosis TAVR, femoral 3.8
6 m 75.1 7.0 2.1 11.4 Elective Stenosis Biological valve Bleeding Bleeding 0.6
7 m 83.2 5.1 1.0 22.9 Elective Stenosis TAVR, apical 2.5
med 61.3
(56.9–68.7)
6.7
(4.0–11.4)
1.5
(1.3–2.0)
7.1
(3.7–10.6)

CABG, coronary artery bypass graft; CASH, cardiac surgery after heart transplantation; ICU, intensive care unit; n.a not available; MOF, multi-organ failure; MV, mitral valve; pt, patient; RRT, renal replacement therapy.